http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2511888-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eefa48f9b21fc8e5b5ceb014f4581255 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 |
| filingDate | 1998-10-08^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-04-14^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c755fe7db024100eba2f32eb7ec9c73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cf54e1fec84f2abbf847ec26dffab84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_264c48190c9f0f4cc511fcfbdf71f629 |
| publicationDate | 2009-04-14^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2511888-C |
| titleOfInvention | Deuterated cyclosporin analogs and their use as immunomodulating agents |
| abstract | Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently-known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution of the cyclosporine A (CsA) molecule by: (1) chemical substitution and optionally deuterium substitution of amino acid 1, and (2) deuterium substitution at key sites of metabolism of the cyclosporine A molecule such as amino acids 1, 4, 9. The most active derivatives of the invention were those possessing both chemical and deuterium substitution. Also disclosed are methods of producing the cyclosporine derivatives and method of producing immunosuppression with reduced toxicity with the disclosed cyclosporine derivatives. |
| priorityDate | 1997-10-08^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 253 of 253.